Edwards Lifesciences Corp (EW) stock
EWNYSEOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 10/3058% above fair value
$105.80−0.01 (-0.01%)
Close on Nov 12, 2026Market cap $60.98BP/E 59.8Yield –
Edwards Lifesciences total assets
Total assets on the balance sheet at the end of each period.
Edwards Lifesciences's total assets was $14.14B at Sep 30, 2026. For fiscal 2025 it was $13.70B, up 4.9% from the year before. Over ten years it grew 12.9% a year on average. The highest annual figure on record is $13.70B in fiscal 2025.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $13.70B | +4.9% |
| FY2024 | Dec 31, 2024 | $13.06B | +39.4% |
| FY2023 | Dec 31, 2023 | $9.36B | +12.9% |
| FY2022 | Dec 31, 2022 | $8.29B | -2.5% |
| FY2021 | Dec 31, 2021 | $8.50B | +17.5% |
| FY2020 | Dec 31, 2020 | $7.24B | +11.5% |
| FY2019 | Dec 31, 2019 | $6.49B | +21.9% |
| FY2018 | Dec 31, 2018 | $5.32B | -6.0% |
| FY2017 | Dec 31, 2017 | $5.67B | +25.6% |
| FY2016 | Dec 31, 2016 | $4.51B | +11.2% |
| FY2015 | Dec 31, 2015 | $4.06B | +15.1% |
| FY2014 | Dec 31, 2014 | $3.52B | +30.0% |
| FY2013 | Dec 31, 2013 | $2.71B | +22.0% |
| FY2012 | Dec 31, 2012 | $2.22B | +12.2% |
| FY2011 | Dec 31, 2011 | $1.98B | +12.1% |
| FY2010 | Dec 31, 2010 | $1.77B | +9.4% |
| FY2009 | Dec 31, 2009 | $1.62B | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $14.14B | +6.6% |
| Q2 FY2026 | Jun 30, 2026 | $13.87B | +2.8% |
| Q1 FY2026 | Mar 31, 2026 | $13.32B | +2.3% |
| Q4 FY2025 | Dec 31, 2025 | $13.70B | +4.9% |
| Q3 FY2025 | Sep 30, 2025 | $13.27B | +2.3% |
| Q2 FY2025 | Jun 30, 2025 | $13.49B | +33.6% |
| Q1 FY2025 | Mar 31, 2025 | $13.02B | +33.7% |
| Q4 FY2024 | Dec 31, 2024 | $13.06B | +39.4% |
| Q3 FY2024 | Sep 30, 2024 | $12.97B | +38.4% |
| Q2 FY2024 | Jun 30, 2024 | $10.10B | +12.2% |
| Q1 FY2024 | Mar 31, 2024 | $9.74B | +12.5% |
| Q4 FY2023 | Dec 31, 2023 | $9.36B | +12.9% |
| Q3 FY2023 | Sep 30, 2023 | $9.37B | +8.5% |
| Q2 FY2023 | Jun 30, 2023 | $9.00B | +6.9% |
| Q1 FY2023 | Mar 31, 2023 | $8.65B | +2.7% |
| Q4 FY2022 | Dec 31, 2022 | $8.29B | -2.5% |
| Q3 FY2022 | Sep 30, 2022 | $8.64B | +5.9% |
| Q2 FY2022 | Jun 30, 2022 | $8.43B | +10.0% |
| Q1 FY2022 | Mar 31, 2022 | $8.42B | +16.7% |
| Q4 FY2021 | Dec 31, 2021 | $8.50B | +17.5% |
| Q3 FY2021 | Sep 30, 2021 | $8.16B | +20.0% |
| Q2 FY2021 | Jun 30, 2021 | $7.66B | +19.3% |
| Q1 FY2021 | Mar 31, 2021 | $7.21B | +18.7% |
| Q4 FY2020 | Dec 31, 2020 | $7.24B | +11.5% |
| Q3 FY2020 | Sep 30, 2020 | $6.80B | +14.0% |
| Q2 FY2020 | Jun 30, 2020 | $6.42B | +15.3% |
| Q1 FY2020 | Mar 31, 2020 | $6.08B | +11.1% |
| Q4 FY2019 | Dec 31, 2019 | $6.49B | +21.9% |
| Q3 FY2019 | Sep 30, 2019 | $5.97B | +0.1% |
| Q2 FY2019 | Jun 30, 2019 | $5.57B | -2.0% |
| Q1 FY2019 | Mar 31, 2019 | $5.47B | -6.1% |
| Q4 FY2018 | Dec 31, 2018 | $5.32B | -6.0% |
| Q3 FY2018 | Sep 30, 2018 | $5.96B | +8.6% |
| Q2 FY2018 | Jun 30, 2018 | $5.69B | +10.7% |
| Q1 FY2018 | Mar 31, 2018 | $5.83B | +21.9% |
| Q4 FY2017 | Dec 31, 2017 | $5.67B | +25.6% |
| Q3 FY2017 | Sep 30, 2017 | $5.49B | – |
| Q2 FY2017 | Jun 30, 2017 | $5.14B | – |
| Q1 FY2017 | Mar 31, 2017 | $4.78B | – |
| Q4 FY2016 | Dec 31, 2016 | $4.51B | – |
See a number that looks wrong?